New Safety Measures for Epilepsy Medication Following Rare Severe Reactions
European regulatory agencies have issued updated safety guidelines for specific anti-seizure medications (ASMs) following reports of rare but severe psychiatric adverse reactions. These measures mandate enhanced patient monitoring to mitigate ... Read More